President Donald Trump is hoping to persuade a Supreme Court with two of his appointees to keep his tax and other financial records from being turned over to lawmakers and a New York district attorney. The justices are hearing arguments by telephone Tuesday in a pivotal legal fight that could affect the presidential campaign, even with the coronavirus outbreak and the resulting economic fallout. Rulings against the president could result in the quick release of personal financial information that Trump has sought strenuously to keep private....
Drugmaker Eli Lilly & Co (LLY) said the U.S. Food and Drug Administration (FDA) approved its drug for lung and thyroid cancer treatmentThe drug selpercatinib, which will be sold under the name of Retevmo, was approved under the FDA's Accelerated Approval regulations based on Phase 1/2 trial's endpoints of objective response rate and duration of response.Selpercatinib is used as an inhibitor for patients with advanced RET-driven lung and thyroid cancers. RET is a genetic mutation which leads to uncontrolled cell growth. The mutations have been found in about 2% of lung cancers and 10%-20% of papillary thyroid cancers."We are extremely proud of how quickly the combined Loxo Oncology and Lilly Oncology teams brought Retevmo to patients, further demonstrating our commitment to delivering life-changing medicines to people living with cancer," said Anne White, president of Lilly Oncology. "Retevmo entered clinical trials in May of 2017 and is now approved less than three...
